scholarly article | Q13442814 |
P2093 | author name string | Doris Mayer | |
Stephanie Lamer | |||
Evelyn Zeindl-Eberhart | |||
Hartmut Manfred Rabes | |||
Peter Roman Jungblut | |||
Sibylle Liebmann | |||
Gundula Jäger | |||
Stephen Chung | |||
Sibylle Haraida | |||
P2860 | cites work | Identification and characterization of a novel human aldose reductase-like gene | Q24310650 |
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members | Q24531853 | ||
An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases | Q28572507 | ||
A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes. | Q30365249 | ||
Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants | Q30724085 | ||
An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management system | Q30736258 | ||
Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma | Q30790833 | ||
Proteome analysis of hepatocellular carcinoma | Q30819488 | ||
Matrix-assisted laser desorption-ionization mass spectrometry peptide mass fingerprinting for proteome analysis: identification efficiency after on-blot or in-gel digestion with and without desalting procedures | Q30984535 | ||
Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma | Q32116795 | ||
New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma | Q34463575 | ||
Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family | Q34474576 | ||
Proteome database of hepatocellular carcinoma. | Q34642472 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
Disease proteomics | Q35084579 | ||
Glutathione transferases and cancer | Q35815703 | ||
Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism | Q37603572 | ||
Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases | Q40602502 | ||
Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry | Q40853089 | ||
Further characterization of a rat hepatoma-derived aldose-reductase-like protein--organ distribution and modulation in vitro | Q41096240 | ||
Expression of tumor-associated protein variants in chemically induced rat hepatomas and transformed rat liver cell lines determined by two-dimensional electrophoresis | Q41484361 | ||
Two-dimensional polyacrylamide gel electrophoresis in experimental hepatocarcinogenesis studies | Q41484368 | ||
Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE) | Q41614723 | ||
Overexpression of aldose reductase in liver cancers may contribute to drug resistance | Q43549654 | ||
The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). | Q43577683 | ||
Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing | Q43582812 | ||
Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis | Q43974879 | ||
Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases | Q44190175 | ||
The aldo-keto reductases and their role in cancer | Q47959317 | ||
A new nomenclature for the aldo-keto reductase superfamily | Q48772502 | ||
A new method to assign immunodetected spots in the complex two-dimensional electrophoresis pattern. | Q50528987 | ||
Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. | Q53011878 | ||
Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. | Q53033706 | ||
Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. | Q53460679 | ||
PUBLIC HEALTH:Reducing Liver Cancer--Global Control of Aflatoxin | Q58296818 | ||
Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes | Q71740598 | ||
Isolation of differentially expressed aldose reductase in ovaries after estrogen withdrawal from hypophysectomized diethylstilbestrol treated rats: increased expression during apoptosis | Q73064967 | ||
Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in rats | Q73990197 | ||
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis | Q74405612 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 540-549 | |
P577 | publication date | 2004-02-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas | |
P478 | volume | 39 |
Q35991845 | A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line. |
Q54364816 | AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer. |
Q52607803 | Aldo-Keto Reductases Mediated Cytotoxicity of 2-Deoxyglucose: A Novel Anticancer Mechanism. |
Q42366521 | Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis |
Q46003997 | Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis. |
Q35893754 | Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling |
Q41128802 | Can proteomics lead to the discovery of real biomarkers for HCC? |
Q36851342 | Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling comp |
Q24294264 | Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids |
Q33764377 | Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis |
Q36227969 | Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma |
Q42199276 | Diallyl sulfide protects against N-nitrosodiethylamine-induced liver tumorigenesis: role of aldose reductase |
Q37538963 | Epithelial-mesenchymal transition induces endoplasmic-reticulum-stress response in human colorectal tumor cells |
Q51069851 | Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry. |
Q37353089 | Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma |
Q33580721 | Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis |
Q33250475 | Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. |
Q38366329 | Glycosylation and liver cancer |
Q33211462 | Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases |
Q27689445 | Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design |
Q33925676 | Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I. |
Q37040963 | Identification of up-regulated genes in malignant glioma with subtraction hybridization: preliminary screening studies |
Q35550716 | Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice. |
Q91726315 | MicroRNAs in Animal Models of HCC |
Q36743649 | Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses |
Q34578790 | Non-alcoholic fatty liver disease proteomics |
Q33298434 | Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. |
Q37105040 | Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10. |
Q35070288 | Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature |
Q39079387 | Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue |
Q38584282 | Proteome Analyses of Hepatocellular Carcinoma |
Q40075098 | Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model |
Q36519019 | Proteomics for the early detection and treatment of hepatocellular carcinoma |
Q89510543 | Retinoic Acids in the Treatment of Most Lethal Solid Cancers |
Q28477432 | ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth |
Q27702584 | Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10 |
Q27649354 | Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10 |
Q41140599 | Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis |